nach oben

Die Ophthalmologie

Erschienen in:

22.07.2020 | Gendermedizin | CME

Gender-Medizin in der Augenheilkunde

Der „kleine Unterschied“ zwischen Frauen und Männern

verfasst von: Prof. Dr. med. M.-A. Gamulescu

Erschienen in: Die Ophthalmologie | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die gender- oder geschlechtsspezifische Medizin ist Teil der „personalisierten“ Medizin. Nachdem seit den 1980er-Jahren zunächst auf dem Gebiet der Kardiologie Unterschiede bei Herzerkrankungen zwischen Frauen und Männern nachgewiesen und verstärkt publiziert wurden, sind auch in anderen Fachbereichen Unterschiede zwischen den Geschlechtern in den Fokus des Interesses gerückt. Immunologische und hormonelle Aspekte lassen auf deutliche Unterschiede z. B. in der Krankheitsausprägung oder der Reaktion auf Therapien schließen. In der Augenheilkunde selbst sind epidemiologische Unterschiede in einigen Erkrankungen bekannt, jedoch führen diese bislang nicht zu einer unterschiedlichen Herangehensweise in der praktischen Behandlung von Patienten. Dieser CME-Beitrag soll das Bewusstsein für die Gender-Medizin auch im Bereich der Augenheilkunde wecken und gleichzeitig auch durch Darstellung der grundlegenden Unterschiede bei den Geschlechtern das Verständnis für ebendiese Unterschiede fördern.

Ludwig S, Dettmer S, Harm P et al (2016) Geschlechtsspezifische Medizin in der Lehre: Noch in den Kinderschuhen. Dtsch Arztebl 113:A-2364 / B‑1944 / C‑1920

Kollock CW (1888) Diseases and functional disorders of the eye, produced by normal and abnormal conditions of the sexual organs. Trans S C Med Assoc, S 97–102

Cornell-Bell AH, Sullivan DA, Allansmith MR (1985) Gender-related differences in the morphology of the lacrimal gland. Invest Ophthalmol Vis Sci 26(8):1170–1175PubMed

Chiamvimonvat V, Sternberg L (1998) Coronary artery disease in women. Can Fam Physician 44:2709–2717PubMedPubMedCentral

Maynard C, Litwin PE, Martin JS et al (1992) Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial Infarction Triage and Intervention Registry. Arch Intern Med 152(5):972–976PubMed

Norberg H, Pranic V, Bergdahl E et al (2020) Differences in medical treatment and clinical characteristics between men and women with heart failure—a single-centre multivariable analysis. Eur J Clin Pharmacol 76(4):539–546. https://doi.org/10.1007/s00228-019-02782-2 CrossRefPubMed

Institute of Medicine (US) (2001) Committee on understanding the biology of sex and gender differences: exploring the biological contributions to human health: does sex matter? The National Academies Press, Washington, DC

Hoffman AJ, Given BA, von Eye A et al (2007) Relationships among pain, fatigue, insomnia, and gender in persons with lung cancer. Oncol Nurs Forum 34(4):785–792PubMed

Potoupnis M, Kenanidis E, Anagnostis P et al (2020) Choosing the approach treatment strategy for osteoporosis in men. Expert Opin Pharmacother 17:1–3. https://doi.org/10.1080/14656566.2020.1743266 CrossRef

10.

WHO (2001) A/RES/55/69, February

11.

Tomlinson A, Phillips C (1970) Applanation tension and axial length of the eyeball. Br J Ophthalmol 54:548PubMedPubMedCentral

12.

Acer N, Sahin B, Ucar T et al (2009) Unbiased estimation of the eyeball volume using the Cavalieri principle on computed tomography images. J Craniofac Surg 20:233–237PubMed

13.

Lee KE, Klein BEK, Klein R et al (2009) Association of age, stature, and education with ocular dimensions in an older white population. Arch Ophthalmol 127:88–93PubMedPubMedCentral

14.

Detorakis ET, Drakonaki E, Papadaki E et al (2010) Effective orbital volume and eyeball position: an MRI study. Orbit 29:244–249PubMed

15.

Özer CM, Öz II, Şerifoğlu I et al (2016) Evaluation of eyeball and orbit in relation to gender and Age. J Craniofac Surg 27(8):e793–e800. https://doi.org/10.1097/SCS.0000000000003133 CrossRefPubMed

16.

Bekerman I, Gottlieb P, Vaiman M (2014) Variations in eyeball diameters of the healthy adults. J Ophthalmol 2014:1–5

17.

Goto T, Klyce SD, Zheng X et al (2001) Gender- and age-related differences in corneal topography. Cornea 20:270–276PubMed

18.

Ananthi S, Santhosh RS, Nila MV et al (2011) Comparative proteomics of human male and female tears by two-dimensional electrophoresis. Exp Eye Res 92:454–463PubMed

19.

Song WK, Lee SC, Lee ES et al (2010) Macular thickness variations with sex, Age, and axial length in healthy subjects: a spectral domain–optical coherence Tomography study. Invest Ophthalmol Vis Sci 51:3913–3918. https://doi.org/10.1167/iovs.09-4189 CrossRefPubMed

20.

Mauschitz MM, Holz FG, Finger RP et al (2019) Determinants of macular layers and optic disc characteristics on SD-OCT: The Rhineland Study. Trans Vis Sci Tech 8(3):34. https://doi.org/10.1167/tvst.8.3.34 CrossRef

21.

Ooto S, Hangai M, Tomidokoro A et al (2011) Effects of Age, sex, and axial length on the three-dimensional profile of normal macular layer structures. Invest Ophthalmol Vis Sci 52:8769–8779. https://doi.org/10.1167/iovs.11-8388 CrossRefPubMed

22.

Maden G, Cakir A, Icar D et al (2017) The distribution of the photoreceptor outer segment length in a healthy population. J Ophthalmol 2017:4641902. https://doi.org/10.1155/2017/4641902 CrossRefPubMedPubMedCentral

23.

Niestrata-Ortiz M, Fichna P, Stankiewicz W et al (2019) Sex-related variations of retinal and Choroidal thickness and foveal avascular zone in healthy and diabetic children assessed by optical coherence Tomography imaging. Ophthalmologica 241(3):173–178. https://doi.org/10.1159/000495622 CrossRefPubMed

24.

Gómez-Ulla F, Cutrin P, Santos P et al (2019) Age and gender influence on foveal avascular zone in healthy eyes. Exp Eye Res. https://doi.org/10.1016/j.exer.2019.107856 CrossRefPubMed

25.

Miyata M, Yoshikawa M, Ohtsuki H, Nagahama Study Group (2018) Age-related change and sex difference over 60s in disc-fovea angle in Japanese population: The Nagahama Study. Acta Ophthalmol 96(7):e840–e845. https://doi.org/10.1111/aos.13642 CrossRefPubMed

26.

Poplin R, Varadarajan AV, Blumer K et al (2018) Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning. Nat Biomed Eng 2(3):158–164. https://doi.org/10.1038/s41551-018-0195-0 CrossRefPubMed

27.

Wickham LA, Gao J, Toda I et al (2000) Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand 78:146–153PubMed

28.

Ogueta S, Schwartz SD, Yamashita CK et al (1999) Estrogen receptor in the human eye: influence of gender and age on gene expression. Invest Ophthalmol Vis Sci 40:1906–1911PubMed

29.

Moss SE, Klein R, Klein BE (2000) Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 118:1264PubMed

30.

Paulsen AJ, Cruickshanks KJ, Fischer ME et al (2014) Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol 157(4):799–806. https://doi.org/10.1016/j.ajo.2013.12.023 CrossRefPubMedPubMedCentral

31.

Schaumberg DA, Buring JE, Sullivan DA et al (2001) Hormone replacement therapy and dry eye syndrome. JAMA 286(17):2114–2119PubMed

32.

Schaumberg DA, Uchino M, Christen WG et al (2013) Patient reported differences in dry eye disease between men and women: impact, management, and patient satisfaction. Plos One 8:e76121PubMedPubMedCentral

33.

Viso E, Rodriguez-Ares MT, Gude F (2009) Prevalence of and associated factors for dry eye in a Spanish adult population (the Salnes Eye Study). Ophthalmic Epidemiol 16:15PubMed

34.

Gagliano C, Caruso S, Napolitano G et al (2014) Low levels of 17-b-oestradiol, oestrone and testosterone correlate with severe evaporative dysfunctional tear syndrome in postmenopausal women: a case control study. Br J Ophthalmol 98:371PubMed

35.

Rahimi Darabad R, Suzuki T, Richards SM et al (2014) Does estrogen deficiency cause lacrimal gland inflammation and aqueous-deficient dry eye in mice? Exp Eye Res 127:153PubMed

36.

Nakamura T, Nishida K, Dota A et al (2001) Elevated expression of transglutaminase 1 and keratinization-related proteins in conjunctiva in severe ocular surface disease. Invest Ophthalmol Vis Sci 42:549PubMed

37.

Ghahfrokhi NA, Vaseghi A, Ghahfarokhi NA et al (2015) Evaluation of corneal alterations during menstrual cycle in productive age women. Indian J Ophthalmol 63:30–32

38.

Klein BEK, Klein R, Linton KLP (1992) Prevalence of age-related lens opacities in a population. Ophthalmology 99:546–552PubMed

39.

Mitchell P, Cumming RG, Attebo K et al (1997) Prevalence of cataract in Australia: the Blue Mountains eye study. Ophthalmology 104:581–588PubMed

40.

Klein BE (1993) Lens opacities in women in Beaver Dam, Wisconsin: is there evidence of an effect of sex hormones? Trans Am Ophthalmol Soc 91:517–544PubMedPubMedCentral

41.

Younan C, Mitchell P, Cumming RG et al (2002) Hormone replacement therapy, reproductive factors, and the incidence of cataract and cataract surgery: the Blue Mountains Eye Study. Am J Epidemiol 155:997–1006PubMed

42.

Zetterberg M, Celojevic D (2015) Gender and cataract—the role of estrogen. Curr Eye Res 40:176–190PubMed

43.

Hulsman CAA, Westendorp ICD, Ramrattan RS et al (2001) Is open-angle glaucoma with early meno-pause? The Rotterdam study. Epidemiol Rev 154:138–144

44.

Vajarannant TS, Grossardt MR, Maki PM et al (2014) The risk of glaucoma after bilateral oophorectomy. Menopause. https://doi.org/10.1097/gme.0b013e31829fd081 CrossRef

45.

Na KS, Jee DH, Han K et al (2014) The ocular benefits of estrogen replacement therapy: A population-based study in postmenopausal Korean women. Plos One 9:e106473PubMedPubMedCentral

46.

Vajaranant TS, Pasquale LR (2012) Estrogen deficiency accelerates ageing of the optic nerve. Menopause 19(8):942–947. https://doi.org/10.1097/gme.0b013e3182443137 CrossRefPubMedPubMedCentral

47.

Sator MO, Akramian J, Joura EA et al (1998) Reducing of intraocular pressure in a glaucoma patient undergoing hormone replacement therapy. Maturitas 29:93–95PubMed

48.

Bouman A, Heineman MJ, Faas MM (2005) Sex hormones and the immune response in humans. Hum Reprod Update 11(4):411–423PubMed

49.

Klein SL (2000) The effects of hormones on sex differences in infection: from genes to behavior. Neurosci Biobehav Rev 24:627–638PubMed

50.

Buggage RR, Matteson DM, Shen DF et al (2003) Effect of sex hormones on experimental autoimmune uveoretinitis (EAU). Immunol Invest 32:259–273PubMed

51.

Miayamoto N, Mandai M, Suzuma I et al (1999) Estrogen protects against cellular infiltration by reducing the expressions of E‑selectin and IL‑6 in endotoxin-induced uveitis. J Immunol 163:374–379

52.

Gritz DC, Wong IG (2004) Incidence and prevalence of uveitis in Northern California; The Northern California Epidemiology of Uveitis Study. Ophthalmology 111:491–500PubMed

53.

Costenbader KH, Feskanich D, Stampfer MJ et al (2007) Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum 56:1251–1262PubMed

54.

Rider V, Li X, Peterson G et al (2006) Differential expression of estrogen receptors in women with systemic lupus erythematosus. J Rheumatol 33:1093–1101PubMed

55.

Baughman RP, Teirstein AS, Judson MA et al (2001) Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164:1885–1889PubMed

56.

Bergamaschi R (2007) Prognostic factors in multiple sclerosis. Int Rev Neurobiol 79:423–447PubMed

57.

Abu-Yaghi NE, Hartono SP, Hodge DO et al (2011) White dot syndromes: a 20-year study of incidence, clinical features, and outcomes. Ocul Immunol Inflamm 19:426–430PubMedPubMedCentral

58.

Wakefield D, Chang JH, Amjadi S et al (2011) What is new HLA-B27 acute anterior uveitis? Ocul Immunol Inflamm 19:139–144PubMed

59.

Marcocci C, Bartalena L, Bogazzi F et al (1989) Studies on the occurrence of ophthalmopathy in Graves’ disease. Acta Endocrinol 120(4):473–478

60.

Magri F, Zerbini F, Gaiti M et al (2016) Gender influences the clinical presentation and long-term outcome of graves disease. Endocr Pract 22:1336–1342PubMed

61.

Schomburg L (2011) Selenium, selenoproteins and the thyroid gland: interactions in health and disease. Nat Rev Endocrinol 8:160–171PubMed

62.

Wang Y, Zhao F, Rijntjes E et al (2019) Role of selenium intake for risk and development of hyperthyroidism. J Clin Endocrinol Metab 104:568–580. https://doi.org/10.1210/jc.2018-01713 CrossRefPubMed

63.

Mitry D, Tuft S, McLeod D et al (2010) Laterality and gender imbalances in retinal detachment. Graefes Arch Clin Exp Ophthalmol 249:1109–1110PubMed

64.

Mahroo OA, Mitry D, Williamson TH et al (2015) Exploring sex and Laterality imbalances in patients undergoing laser Retinopexy. JAMA Ophthalmol 133:1334–1336. https://doi.org/10.1001/jamaophthalmol.2015.2731 CrossRefPubMed

65.

Wang J, McLeod D, Henson DB et al (2003) Age-dependent changes in the basal retinovitreous adhesion. Invest Ophthalmol Vis Sci 44:1793–1800PubMed

66.

Lin LL, Shih YF, Hsiao CK et al (2000) Epidemiologic study of the prevalence and severity of myopia among schoolchildren in Taiwan in 2000. J Formos Med Assoc 100:684–691

67.

Chen ZTY, Wang IJ, Liao YT et al (2011) Poplymorphisms in steroidogenesis genes, sex steroid levels, and high myopia in the Taiwanese population. Mol Vis 17:2297–2310PubMedPubMedCentral

68.

The Eye Disease Case-Control Study Group (1994) Risk factors for idiopathic macular holes. Am J Ophthalmol 118(6):754–761

69.

McCannel CA, Ensminger JL, Diehl NN et al (2009) Population based incidence of macular holes. Opthalmology 116:1366–1369

70.

Qiu QH, Chen ZY, Yin LL et al (2012) Effects of estrogen on collagen gel contraction by human retinal glial cells. Chin Med J 125(22):4098–4103PubMed

71.

Inokuchi N, Ikeda T, Nakamura K et al (2015) Vitreous estrogen levels in patients with an idiopathic macular hole. Clin Ophthalmol 9:549–552. https://doi.org/10.2147/OPTH.S80754 CrossRefPubMedPubMedCentral

72.

Gray RH, Gregor ZJ, Marsh M (1994) Oestrogens and macular holes: a postal questionnaire. Eye (lond) 8(Pt 3):368–369

73.

Kajiwara A, Miyagawa H, Saruwatari J et al (2014) Gender differences in the incidence and progression of diabetic retinopathy among Japanese patients with type 2 diabetes mellitus: a clinic-based retrospective longitudinal study. Diabetes Res Clin Pract 103:e7–e10PubMed

74.

Schiefelbein J, Müller M, Kern C et al (2020) Gender-related differences in patients treated with intravitreal anti-vascular endothelial growth factor medication for diabetic macular oedema. Eur J Ophthalmol. https://doi.org/10.1177/1120672119899627 CrossRefPubMed

75.

Kitzmann AS, Pulido JS, Diehl NN et al (2008) The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980–2002. Ophthalmology 115:169–173PubMed

76.

Spaide RF, Campeas L, Haas A et al (1996) Central serous chorioretinopathy in younger and older adults. Ophthalmology 103:2070–2080. https://doi.org/10.1016/s0161-6420(96)30386-2 CrossRefPubMed

77.

Hanumunthadu D, Van Dijk EHC, Gangakhedkar S et al (2018) Gender variation in central serous chorioretinopathy. Eye (lond) 32(11):1703–1709. https://doi.org/10.1038/s41433-018-0163-7 CrossRef

78.

Schellevis RL, Altay L, Kalisingh A et al (2019) Elevated steroid hormone levels in active chronic central serous Chorioretinopathy. Invest Ophthalmol Vis Sci 60(10):3407–3413. https://doi.org/10.1167/iovs.19-26781 CrossRefPubMed

79.

Klein R, Klein BE, Linton KL (1992) Prevalence of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 99:933–943PubMed

80.

Mitchell P, Smith W, Attebo K et al (1995) Prevalence of age-related maculopathy in Australia: The Blue Mountains Eye Study. Ophthalmology 102:1450–1460PubMed

81.

Vingerling J, Dielemans I, Hofman A et al (1995) The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 102:205–210PubMed

82.

Rudnicka AR, Jarrar Z, Wormald R et al (2012) Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 119(3):571–580. https://doi.org/10.1016/j.ophtha.2011.09.027 CrossRefPubMed

83.

Winkler TW, Brandl C, Grassmann F et al (2018) International Age-related Macular Degeneration Genomics Consortium (IAMDGC). Investigating the modulation of genetic effects on late AMD by age and sex: Lessons learned and two additional loci. Plos One 13(3):e194321. https://doi.org/10.1371/journal.pone.0194321 CrossRefPubMedPubMedCentral

84.

Kawasaki R, Yasuda M, Song SJ et al (2010) The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology 117:921–927. https://doi.org/10.1016/j.ophtha.2009.10.007 CrossRefPubMed

85.

Kwon HJ, Lee SM, Pak KY et al (2017) Gender differences in the relationship between sex hormone deficiency and soft Drusen. Curr Eye Res 42(11):1527–1536. https://doi.org/10.1080/02713683.2017.1337155 CrossRefPubMed

86.

Vingerling JR, Dielemans I, Witteman JC et al (1995) Macular degeneration and early menopause: a case-control study. BMJ 310(6994):1570–1571PubMedPubMedCentral

87.

Eye Disease Case-Control Study Group (1992) Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 110:1701–1708

88.

Snow KK, Cote J, Yang W et al (2002) Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women. Am J Ophthalmol 134:842–848PubMed

89.

Smith W, Mitchell P, Wang JJ (1997) Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study. Aust N Z J Ophthalmol 25(Suppl 1):S13–S15PubMed

90.

Edwards DR, Gallins P, Polk M et al (2010) Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms. Invest Ophthalmol Vis Sci 51(4):1873–1879. https://doi.org/10.1167/iovs.09-4000 CrossRefPubMedPubMedCentral

91.

Haan MN, Klein R, Klein BE et al (2006) Hormone therapy and age-related macular degeneration: the Women’s Health Initiative Sight Exam Study. Arch Ophthalmol 124:988–992PubMed

92.

Cho B‑J, Heo JW, Shin JP et al (2014) Association between reproductive factors and Age-related macular degeneration in postmenopausal women: the Korea national health and nutrition examination survey 2010-2012. Plos One 9(7):e102816. https://doi.org/10.1371/journal.pone.0102816 CrossRefPubMedPubMedCentral

93.

Schwarz EB, Ray RM, Stuebe AM et al (2009) Duration of lactation and risk factors for maternal cardiovascular disease. Obstet Gynecol 113:974–982PubMedPubMedCentral

94.

Connell PP, Keane PA, O’Neill EC et al (2009) Risk factors for age-related maculopathy. J Ophthalmol. https://doi.org/10.1155/2009/360764 CrossRefPubMedPubMedCentral

95.

Grassmann F, Friedrich U, Fauser S et al (2015) A candidate gene association study identifies DAPL1 as a female-specific susceptibility locus for Age-related macular degeneration (AMD). Neuromol Med 17:111–120. https://doi.org/10.1007/s12017-015-8342-1 CrossRef

96.

Sasaki M, Harada S, Kawasaki Y et al (2018) Gender-specific association of early age-related macular degeneration with systemic and genetic factors in a Japanese population. Sci Rep 8:785. https://doi.org/10.1038/s41598-017-18487-4 CrossRefPubMedPubMedCentral

97.

Giordano L, Deceglie S, d’Adamo P et al (2015) Cigarette toxicity triggers Leber’s hereditary optic neuropathy by affecting mtDNA copy number, oxidative phosphorylation and ROS detoxifiation pathways. Cell Death Dis 6:e2021. https://doi.org/10.1038/cddis.2015.364 CrossRefPubMedPubMedCentral

98.

Giordano C, Montopoli M, Perli E et al (2011) Oestrogens ameliorate mytochondrial dysfunction in Leber’s hereditary optic neuropathy. Brain 134:220–234PubMed

Titel: Gender-Medizin in der Augenheilkunde
Der „kleine Unterschied“ zwischen Frauen und Männern
verfasst von: Prof. Dr. med. M.-A. Gamulescu
Publikationsdatum: 22.07.2020
Verlag: Springer Medizin
Schlagwörter: Gendermedizin
Uveitis
Östrogene
Erschienen in: Die Ophthalmologie / Ausgabe 8/2020
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI: https://doi.org/10.1007/s00347-020-01174-7

Neu im Fachgebiet Augenheilkunde

08.04.2024 | Therapieverfahren in der Augenheilkunde | CME

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Gender-Medizin in der Augenheilkunde

Der „kleine Unterschied“ zwischen Frauen und Männern

Zusammenfassung

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2020

Akute makuläre Neuroretinopathie bei einer 13-jährigen Patientin mit fokaler choroidaler Exkavation und Pachychoroid

Offene Bindehautrevision nach XEN45-Gel-Stent-Implantation als standardisiertes Verfahren

Von humanen terrestrischen Modellen zu neuen Präventionsansätzen für Augenveränderungen bei Astronauten

„Descemet membrane endothelial keratoplasty“ DMEK – Spender und Empfänger Schritt für Schritt

Lageabhängigkeit des Augeninnendruckes bei Glaukompatienten

Viva Voce des EBO (European Board of Ophthalmology) Diploma: Prüfung unter Kollegen

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde